Product Browser

Last updated: 2017/7/23

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

ART4 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00000420-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-ART4 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 34.65
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-ART4 antibody (H00000420-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00000420-T01
    ART4 transfected lysate.
    Western Blot
    QC Testing of H00000420-T01
    Lane 1: ART4 transfected lysate ( 34.65 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 420
  • Gene Name:
  • ART4
  • Gene Alias:
  • CD297,DO,DOK1
  • Gene Description:
  • ADP-ribosyltransferase 4 (Dombrock blood group)
  • Gene Summary:
  • This gene encodes a protein that contains a mono-ADP-ribosylation (ART) motif. It is a member of the ADP-ribosyltransferase gene family but enzymatic activity has not been demonstrated experimentally. Antigens of the Dombrock blood group system are located on the gene product, which is glycosylphosphatidylinosotol-anchored to the erythrocyte membrane. Allelic variants, some of which lead to adverse transfusion reactions, are known. [provided by RefSeq
  • Other Designations:
  • ADP-ribosyltransferase 4,ADP-ribosyltransferase 4 (DO blood group),Dombrock blood group carrier molecule,mono-ADP-ribosyltransferase 4
  • RSS
  • YouTube
  • Linkedin
  • Facebook